These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 37272857)

  • 1. Magnetic seizure therapy for people with schizophrenia.
    Wu H; Jiang J; Cao X; Wang J; Li C
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD012697. PubMed ID: 37272857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroconvulsive therapy for treatment-resistant schizophrenia.
    Sinclair DJ; Zhao S; Qi F; Nyakyoma K; Kwong JS; Adams CE
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011847. PubMed ID: 30888709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
    Huang MW; Gibson RC; Jayaram MB; Caroff SN
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013100. PubMed ID: 35844143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modafinil for people with schizophrenia or related disorders.
    Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wendan decoction (Traditional Chinese medicine) for schizophrenia.
    Deng H; Xu J
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012217. PubMed ID: 28657646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective noradrenaline reuptake inhibitors for schizophrenia.
    Matthews PRL; Horder J; Pearce M
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010219. PubMed ID: 29368813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia.
    Ballesteros J; Moreno-Calvete MC; Santos-Zorrozúa B; González-Fraile E
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013511. PubMed ID: 37490701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic seizure therapy for treatment-resistant depression.
    Jiang J; Zhang C; Li C; Chen Z; Cao X; Wang H; Li W; Wang J
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013528. PubMed ID: 34131914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia.
    Bighelli I; Rodolico A; Siafis S; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014383. PubMed ID: 36042158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation (TMS) for schizophrenia.
    Dougall N; Maayan N; Soares-Weiser K; McDermott LM; McIntosh A
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD006081. PubMed ID: 26289586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zuclopenthixol dihydrochloride for schizophrenia.
    Bryan EJ; Purcell MA; Kumar A
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005474. PubMed ID: 29144549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.
    Jones C; Hacker D; Xia J; Meaden A; Irving CB; Zhao S; Chen J; Shi C
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD007964. PubMed ID: 30572373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia.
    Saha KB; Bo L; Zhao S; Xia J; Sampson S; Zaman RU
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010631. PubMed ID: 27045703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia.
    Rodolico A; Siafis S; Bighelli I; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014384. PubMed ID: 36420692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine adjunct for people with schizophrenia.
    Perry LA; Ramson D; Stricklin S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011943. PubMed ID: 29802811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture for schizophrenia.
    Shen X; Xia J; Adams CE
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005475. PubMed ID: 25330045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk assessment for aggressive behaviour in schizophrenia.
    Välimäki M; Lantta T; Kontio R
    Cochrane Database Syst Rev; 2024 May; 5(5):CD012397. PubMed ID: 38695777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.